A group of medical and scientific experts recently wrote to President Rodrigo Duterte, urging him to sign the pending Electronic Cigarette Bill into law.
On July 8, a group of scholars, healthcare professionals, and researchers, including Dr. Jose Dante Dator, former director of the National Kidney and Transplant Institute; Dr. Rafael Castillo, former president of the Philippine Heart Association and the Asia-Pacific Society of Hypertension; Dr. Arleen Reyes, former president of the Philippine Dental Association; Dr. Romeo Luna, president of the San Juan Medical Center Employees Association; Dr. Telesforo Gana, former president of the Philippine Urological Association; Dr. Fernando Fernandez, former dean of the College of Dentistry at the Philippine Academy of Maxillofacial Surgeons; Howard Enriquez, former president of the Philippine Society of Otolaryngology Head and Neck Surgery; and Dr. Alvin Laxamana, former president of the Philippine Dental Association, signed a letter to Marcos via his executive secretary Victor Rodriguez.
An advocacy group is calling for the enactment of the "E-Cigarette Bill" to provide comprehensive regulation of safer nicotine alternatives such as electronic cigarettes and heated tobacco products. They argue that ultimately, e-cigarettes can help smokers quit and reduce the number of deaths and illnesses caused by smoking. "If this bill becomes law, it presents a tremendous opportunity that we cannot afford to miss, as it has the potential to improve the quality of life for smokers and improve long-term outcomes," they said.
Similarly, a recent survey conducted by the Asia Research Network in the Philippines found that 90% of local smokers would support a public health strategy that advocates for the use of safer nicotine alternatives, such as electronic cigarettes, for smoking cessation.
Automatically becomes a law.
The bill is the coordinated version of Senate Bill 2239, also known as the "Electronic Nicotine Delivery Systems and Non-Nicotine Delivery Systems Regulation Act." The aim of the bill is to regulate the importation, manufacture, sale, packaging, distribution, use, and consumption of electronic cigarettes and heated tobacco products (HTPs) using internationally recognized standards, in order to protect citizens from harm caused by unregulated and substandard products. The bill also aligns with House Bill 9007, also known as the "Regulating Non-Combustible Nicotine Delivery Systems Act.
The bill was approved on June 24 by former President Rodrigo Duterte and his successor, Ferdinand Marcos Jr. The president has 30 days to either sign the bill into law or veto it. However, when neither of them took any action, the bill automatically became law on July 25.
Statement:
This article is compiled based on information from third-party sources and is intended for industry discussion and learning purposes.
This article does not reflect the views of 2FIRSTS and we cannot confirm the truth or accuracy of its contents. The translation of this article is solely intended for industry exchange and research purposes.
Due to limitations in our translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign related statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
